Some progress has been made towards these goals. For instance, in recent tests human embryonic stem cell-derived hepatocytes performed as well as the current FDA gold standard primary adult cells at predicting human hepatotoxicity (Szkolnicka D et al., 2014). However, the ability to control the differentiation of both tissue and pluripotent stem cells remains a challenge for the field.
No comments:
Post a Comment